DE MPJE key terms

The state regulatory body that licenses pharmacies and pharmacy personnel, adopts regulations under the Pharmacy Practice Act, and disciplines licensees. It operates within the Division of Professional Regulation.

The Delaware state agency that houses the professional licensing boards, including the Board of Pharmacy, and provides investigative and administrative support for licensing and disciplinary matters.

Delaware's statutory framework, in Title 24 of the Delaware Code, governing pharmacist and pharmacy licensure, scope of practice, dispensing, and Board authority. Regulations adopted by the Board implement and interpret it.

A rule adopted by the Delaware Board of Pharmacy under statutory authority that fills in operational detail, such as recordkeeping, labeling, counseling, and technician ratios. Regulations carry the force of law.

The Delaware-licensed pharmacist designated on a pharmacy permit as responsible for the pharmacy's day-to-day compliance with law, including records, security, staffing, and supervision of personnel.

The license issued by the Delaware Board of Pharmacy authorizing a specific location to operate as a pharmacy. It is tied to the premises and to the designated pharmacist-in-charge.

The credential issued by the Delaware Board allowing an individual to practice pharmacy in the state, obtained through education, examination, and internship requirements and maintained by renewal and continuing education.

A person registered with the Delaware Board who is gaining the supervised practical experience required for pharmacist licensure. Interns may perform pharmacist duties only under required supervision.

A Board-registered supportive person who assists pharmacists with dispensing and related tasks under pharmacist supervision. Delaware rules limit what technicians may do and how many may be supervised.

The regulatory limit on how many registered technicians one pharmacist may supervise at a given time. The ratio differs depending on whether the pharmacist is performing certain clinical or distributive functions.

A standard requiring a supervising pharmacist to be physically present in the pharmacy and immediately available to oversee the activities of interns, technicians, or other assistive personnel.

A pharmacy located outside Delaware that ships prescriptions to Delaware patients and must register with the Delaware Board, meeting state-specific labeling, counseling, and inspection requirements.

The pharmacist's duty to offer verbal information to the patient or caregiver about a new or changed prescription, including directions, precautions, and interactions, unless the patient declines.

The mandated contents of a dispensed prescription label in Delaware, such as pharmacy identity, patient name, drug name and strength, directions, quantity, date, prescriber, and required cautionary statements.

The documentation a Delaware pharmacy must keep for each dispensing, including prescriber, patient, drug, quantity, date, and pharmacist identity, retained for the period set by Board regulation.

The regulatory period during which a Delaware pharmacy must keep prescription, purchasing, and controlled substance records available for inspection by the Board or other authorized agents.

An examination of a pharmacy's premises, equipment, and records by Board representatives or authorized agents to verify compliance with Delaware pharmacy law and regulations.

The credit hours a Delaware pharmacist must complete each renewal cycle, including any mandated topic hours, to maintain an active license. Records must be retained and produced on audit.

The periodic process by which a Delaware pharmacist or pharmacy renews its credential, submitting fees and attesting to continuing education and other compliance obligations by the Board's deadline.

The communication of prescription information from one pharmacy to another to permit dispensing elsewhere. Delaware rules govern who may send or receive a transfer and how it is documented.

The prescriber's permission, including any specified number of refills or time limit, allowing a pharmacy to dispense a prescription again without a new order.

Dispensing a therapeutically equivalent lower-cost product in place of the prescribed brand, as permitted by Delaware law, unless the prescriber indicates that substitution is prohibited.

A written arrangement between a pharmacist and a prescriber authorizing the pharmacist to manage drug therapy, including initiating or adjusting medications, under defined protocols and documentation requirements.

Delaware's statute, in Title 16 of the Delaware Code, regulating the manufacture, distribution, dispensing, and possession of controlled substances and establishing schedules and registration requirements.

One of five ranked categories in Delaware law classifying substances by abuse potential and accepted medical use. The schedule determines prescribing limits, recordkeeping, and security obligations.

A controlled substance with high abuse potential and recognized medical use, subject to the strictest dispensing rules, including written or emergency oral prescriptions and no refills.

A controlled substance with moderate abuse potential and accepted medical use. Delaware rules permit limited refills within a set period and impose recordkeeping and security requirements.

A controlled substance with lower abuse potential than Schedule III but recognized dependence risk, subject to prescription, refill, and recordkeeping controls under Delaware and federal law.

The least restricted controlled substance schedule, covering preparations with low abuse potential. Some may be dispensed without a prescription under conditions and recordkeeping rules set by law.

The Delaware credential a practitioner or facility must hold, in addition to any federal registration, to prescribe, administer, or dispense controlled substances in the state.

The federal registration issued by the Drug Enforcement Administration that authorizes a practitioner or entity to handle controlled substances. Delaware requires state authorization as well.

Delaware's database collecting dispensed controlled substance prescriptions, which dispensers must report and authorized prescribers and pharmacists may query to identify risky use patterns.

The obligation for prescribers and pharmacists to check the Delaware prescription monitoring program in specified situations, such as initial opioid prescribing or signs of misuse.

An oral Schedule II order permitted when immediate dispensing is needed, limited in quantity and requiring the prescriber to furnish a written follow-up prescription within the required time.

The maximum number of times a controlled substance prescription may be refilled, and the outer time limit for dispensing refills, as set by the schedule and Delaware law.

Dispensing less than the full quantity prescribed, permitted in defined circumstances such as Schedule II quantity limits or patient or prescriber request, with the balance handled per regulation.

A running, continuously updated record of controlled substances received and dispensed that a Delaware pharmacy must maintain to reconcile stock and detect losses or diversion.

The complete count of controlled substances on hand that a registered pharmacy must conduct at least every two years, documenting quantities and retaining the record for inspection.

The duty to notify the appropriate state and federal authorities when controlled substances are discovered missing or diverted, and to document the circumstances and quantities involved.

The physical safeguards, such as locked storage and restricted access, that a Delaware pharmacy must use to prevent unauthorized access to controlled substances on the premises.